Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PCI Biotech Holding ASA ( (DE:4QG) ) has shared an update.
Euronext Oslo Børs has placed PCI Biotech Holding ASA in its Recovery Box compartment as of 30 January 2026, a segment reserved for securities where issuer-specific circumstances make pricing particularly uncertain. The company’s shares will remain there until those uncertainties are resolved, signalling heightened risk and closer market scrutiny for investors.
The exchange also discloses that other issuers are in the Recovery Box and Penalty Bench, compartments used when pricing is uncertain or when companies fail to comply with listing rules. These measures underline Oslo Børs’ use of special segments to manage regulatory breaches and transparency around risk, potentially affecting liquidity, investor confidence, and trading conditions for the affected securities.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a biotechnology company listed on Euronext Oslo Børs. It operates in the life sciences sector, with its shares traded on the Norwegian market and subject to the exchange’s specific compartments and regulatory frameworks for issuers facing elevated risk or rule-compliance issues.
YTD Price Performance: -17.07%
Average Trading Volume: 754,002
Current Market Cap: NOK7.61M
For detailed information about 4QG stock, go to TipRanks’ Stock Analysis page.